Hereditary angioedema is a rare genetic disease that causes episodes of severe swelling. The swelling can occur in the limbs, face, intestinal tract and elsewhere. Sometimes, it can be life threatening if the swelling obstructs breathing. Though there are limited therapeutic options available, a class of drugs known as RNA interference is offering hope. We spoke to Marc Riedl, MD, Professor of Medicine and Clinical Director of the US HAEA Angiodema Center at the University of California, San Diego, about Hereditary Angioedema, how RNA interference therapies work, and why this may be an area of promise for this and other rare diseases.

Daniel S. Levine is an award-winning business journalist who has reported on the life sciences, economic development, and business policy issues throughout his 25-year career. He founded Levine Media Group in 2013 to provide strategic communications to life sciences companies. He is host of The Bio Report and RARECast podcasts, a senior fellow at the Center for Medicine in the Public Interest, and a member of the advisory board of the California Biotechnology Council.

Are you a patient or caregiver with hereditary angiodema? What treatment options have you explored?

Learn more about Marc Riedl and how you can listen to his presentation at the Global Genes 2016 Patient Advocacy Summit by clicking here.

1 thought on “RARECast: The Promise of RNAi for Hereditary Angioedema and Other Rare Diseases”

  1. Yvonne Stoner says:

    I was born with HAE. I have lived with it my entire life. There is not a place on my body that has not been affected by this disease. And now I see that the things that have worked for me all my life are not to be used, so that more expensive medications can be used instead. I know what works for me. I have survived using Epinephrine, antihistamines and steroids for 58 years. Why should I try something that gives me more , better hope, but is out of my reach financially?

Comments are closed.